Calidi Biotherapeutics (CLDI) News Today $2.19 +0.18 (+8.96%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ### Calidi Biotherapeutics (NYSE: CLDI) Announces Completion of $7.5 Million Public OfferingSAN DIEGO, November 15, 2024 - Calidi Biotherapeutics Inc. (NYSE American: CLDI) successfully concluded a public offering, as detailed in the company's recentNovember 17 at 4:15 AM | americanbankingnews.comAnalyzing Adverum Biotechnologies (NASDAQ:ADVM) and Calidi Biotherapeutics (NYSE:CLDI)November 16 at 3:21 AM | americanbankingnews.comCalidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common StockNovember 15 at 4:05 PM | globenewswire.comCalidi prices 4.4M shares at $1.69 in public offeringNovember 14 at 2:52 PM | markets.businessinsider.comCalidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common StockNovember 14 at 8:30 AM | globenewswire.comCalidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer NewsNovember 14 at 2:17 AM | marketwatch.comCalidi Biotherapeutics Announces Proposed Public OfferingNovember 13, 2024 | globenewswire.comCalidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial ResultsNovember 12, 2024 | globenewswire.comCalidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV ProgramOctober 29, 2024 | theglobeandmail.comCalidi Biotherapeutics (NYSE American: CLDI) to Present Antitumor Virotherapy Platform Data at ConferencesOctober 28, 2024 | theglobeandmail.comCalidi to present data supporting RTNova at upcoming conferencesOctober 25, 2024 | markets.businessinsider.comCalidi to sell 2.05M shares at $1.00 in registered direct offeringOctober 24, 2024 | finance.yahoo.comCalidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific ConferencesOctober 24, 2024 | globenewswire.comWhy Calidi Biotherapeutics (CLDI) Stock Is Down 13%October 23, 2024 | benzinga.comCalidi Biotherapeutics stock tumbles on $2M securities offeringOctober 23, 2024 | msn.comCalidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private PlacementOctober 23, 2024 | globenewswire.comCalidi Biotherapeutics Faces Warrant Delisting by NYSEOctober 20, 2024 | markets.businessinsider.comCalidi Biotherapeutics (NYSE:CLDI) Stock Price Up 3.4% - Should You Buy?Calidi Biotherapeutics (NYSE:CLDI) Trading Up 3.4% - Time to Buy?October 19, 2024 | marketbeat.comNYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)October 18, 2024 | globenewswire.comNYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)October 18, 2024 | finance.yahoo.comWendy PizarroOctober 13, 2024 | latimes.comCalidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade GliomaSeptember 30, 2024 | finance.yahoo.comCalidi Biotherapeutics (NYSE:CLDI) Posts Earnings Results, Beats Expectations By $0.03 EPSCalidi Biotherapeutics (NYSE:CLDI - Get Free Report) announced its earnings results on Tuesday. The company reported ($1.40) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.43) by $0.03.August 14, 2024 | marketbeat.comCalidi Biotherapeutics, Inc: Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial ResultsAugust 14, 2024 | finanznachrichten.deCalidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial ResultsAugust 13, 2024 | globenewswire.comCalidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald RigorJuly 29, 2024 | globenewswire.comCalidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology PlatformJuly 18, 2024 | globenewswire.comCalidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory BoardJuly 16, 2024 | globenewswire.comCalidi to Effect Reverse Stock SplitJuly 5, 2024 | businesswire.comCalidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13June 11, 2024 | businesswire.comCalidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid TumorsJune 10, 2024 | businesswire.comCalidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual MeetingJune 3, 2024 | businesswire.comCalidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross ProceedsMay 31, 2024 | businesswire.comCalidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone Show on Bloomberg TVMay 17, 2024 | finanznachrichten.deCLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q1 2024May 15, 2024 | investorplace.comCalidi Biotherapeutics Reports First Quarter 2024 Operating and Financial ResultsMay 14, 2024 | businesswire.comCalidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual MeetingMay 1, 2024 | businesswire.comJoin Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24April 23, 2024 | finance.yahoo.comJoin Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24April 23, 2024 | businesswire.comCalidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public OfferingApril 19, 2024 | businesswire.comWhy Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%April 16, 2024 | msn.comWhy Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today?April 16, 2024 | investorplace.comCalidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public OfferingApril 16, 2024 | businesswire.comCalidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024April 9, 2024 | finance.yahoo.comCalidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024April 9, 2024 | businesswire.comCLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023March 16, 2024 | investorplace.comCalidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial ResultsMarch 15, 2024 | businesswire.comCalidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian CancerMarch 11, 2024 | businesswire.comCalidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming ConferenceFebruary 12, 2024 | finance.yahoo.comCalidi Biotherapeutics Shares Informal Financial UpdateFebruary 8, 2024 | msn.com Get Calidi Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CLDI and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this if you missed cheap Bitcoin (Ad)Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Because a new blockchain is taking the world by storm… It’s seeing rapid adoption amongst crypto fans… And just now starting to break into the mainstream. While I cannot promise future returns or against losses… This might not just be another chance at Bitcoin-like gains… It could be EVEN bigger. But this market is moving fast… So if you want a shot at getting in on what could be the ground floor Click Here for Details. CLDI Media Mentions By Week CLDI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLDI News Sentiment▼0.550.56▲Average Medical News Sentiment CLDI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLDI Articles This Week▼91▲CLDI Articles Average Week Get Calidi Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CLDI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PowerUp Acquisition News Today MediciNova News Today Genenta Science News Today Coherus BioSciences News Today I-Mab News Today Werewolf Therapeutics News Today PDS Biotechnology News Today PMV Pharmaceuticals News Today BioAtla News Today Ikena Oncology News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CLDI) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
